Neuropsychiatric manifestations after mefloquine therapy for plasmodium falciparum malaria: Comparing a retrospective and a prospective study

Tropical Medicine and International Health

Volumn 3, Issue 2, 1998, Pages 83-88

  Ronn A M ^a   Ronne Rasmussen J ^a   Gotzsche P C ^a   Bygbjerg, I C ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Adverse reactions; Malaria; Mefloquine; Neuropsychiatric; Retrospective and prospective studies

Indexed keywords

CHLOROQUINE; MEFLOQUINE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DEPRESSION; FEMALE; HALLUCINATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALARIA; MALE; MANIA; MENTAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; NIGHTMARE; PARESTHESIA; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDY; RESTLESSNESS; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; TREMOR; VERTIGO; VOMITING;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIMALARIALS; BIAS (EPIDEMIOLOGY); FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RESEARCH DESIGN; RETROSPECTIVE STUDIES;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031953112     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1998.00163.x     Document Type: Article

References (34)

1. Ahn TK , Van Kim N, Arnold K et al. (1990) Double-bind studies with mefloquine alone and in combination with sulfadoxinepyrimethamine in 120 adults and 120 children with falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 50-53.
2. Barrett PJ, Emmins PD, Clarke PD & Bradley DJ (1996) Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. British Medical Journal 313, 525-528.
3. Bernard J, Le Camus J & Sarrouy J (1987) Encephalopathie toxique a la mefloquine. Presse Médicale 16, 1654-1655.
4. Bernard J, Le Camus J, Sarrouy J et al. (1989) Encephalopathie toxique àla mefloquine. A propos de trois observations. Médecine et Armées 17, 209-211.
5. Caillon E, Schmitt L & Moron P (1992) Acute depressive symptoms after mefloquine treatment. American Journal of Psychiatry 149, 712.
6. Dankwa E & Martin P (1997) Review on Adverse Events Associated with Lariam (mefloquine) Period: January 1 to December 31, 1996. Research Report. F. Hoffmann- La Roche Ltd, Basel, Switzerland.
7. De Gennes C, Colas C & Nollet D et al. (1992) Attaque de panique au decours d'un traitement curatif par la mefloquine. Annales Medicine Interne 142, 631.
8. Ekue JMK, Ulrich AM, Rwabwogo-Atenyi J & Sheth UK (1983) A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria. Bulletin of the World Health Organization 61, 713-718.
9. F Hoffmann-La Roche (1993) Adverse events from spontaneous reporting associated with Lariam. F. Hoffmann La-Roche Ltd, Basel, Switzerland.
10. Harinasuta T, Bunnag D & Wernsdorfer WH (1983) A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Bulletin of the World Health Organization 61, 299-305.
11. Harinasuta T, Bunnag D, Lasserre R, Leimer R & Vinijanont S (1985) Trials of mefloquine in vivax and of mefloquine plus 'Fansidar' in falciparum malaria. Lancet i, 885-888.
12. Hennequin C, Bouree P, Bazin N, Bisaro F & Feline A (1994) Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Archives of Internal Medicine 154, 2360-2362.
13. Luxemburger C, Nosten F, ter Kuile FO, Frejacques L, Chongsuphajaisiddhi T & White NJ (1991) Mefloquine for multidrug-resistant malaria. Lancet 338, 1268.
14. Magnussen P & Bygbjerg IC (1990) Treatment of Plasmodium falciparum malaria with mefloquine alone or in combination with IV quinine at the Department of Communicable and Tropical Diseases, Rigshospitalet, Copenhagen 1982-1988. Danish Medical Bulletin 37, 563-564.
15. Mai NTH, Day NPJ, Chuong LV et al. (1996) Post-malaria neurological syndrome. Lancet 348, 917-921.
16. Marsepoil T, Petithory J, Faucher JM, Ho P, Viriot E & Benaiche F (1993) Encephalopathic et troubles amnesiques au cours des traitements par la mefloquine. Revue Medicine Interne 14, 788-791.
17. Palmer KJ, Holliday SM & Brogden RN (1993) Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 45, 430-475.
18. Patchen LC, Campbell CC & Williams SB (1989) Neurological reactions after a therapeutic dose of mefloquine. New England Journal of Medicine 321, 1415.
19. Phillips-Howard PA & ter Kuile FO (1995) CNS Adverse events associated with antimalarial agents. Facts or fiction? Drug Safety 12, 370-383.
20. Rønn AM & Bygbjerg IC (1994) Acute brain syndrome following mefloqmne treatment. Ugeskrift for Lœger 156, 6044-6045.
21. Rouveix B, Bricaire F, Michon C et al. (1989) Mefloquine and an acute brain syndrome. Annals of Internal Medicine 110, 577-578.
22. Schlagenhauf P, Steffen R, Lobel H et al. (1996) Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Tropical Medicine and International Health 1, 485-494.
23. Silva HJD, Hoang P, Dalton H, Silva NR, Jewell DP & Peiris JB (1992) Immune activation during cerebellar dysfunction following Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 129-131.
24. Sowunmi A (1994) Acute psychosis after mefloquine: a case report. East African Medical Journal 71, 818-819.
25. Sciwunmi A, Salako LA, Ocluola AMJ, Walker O, Akindele JA & Ogunclahunsi OAT (1993) Neuropsychiatric side effects of mefloquine in Africans. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 462-463.
26. Sowunmi A, Adio RA, Oduola AMJ, Ogundahunsi OAT & Salako LA (1995) Acute psychosis after mefloquine. Tropical and Geographical Medicine 47, 178-180.
27. Speich R & Haller A (1994) Central anticholinergic syndrome with the antimalarial drug mefloquine. New England Journal of Medicine 331, 57-58.
28. Stuiver PC, Lighthelm RJ & Goud TJLM (1989) Acute psychosis after mefloquine. Lancet 2, 282.
29. ter Kuile FO (1994) Mefloquine, halofantrine and artesunate in the treatment of uncomplicated falciparum malaria in a multi-drug resistant area. Unpublished Ph.D thesis, University of Amsterdam.
30. ter Kuile FO, Nosten F, Luxemburger C et al. (1995) Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bulletin of the World Health Organization 73, 631-642.
31. Thimasarn K, Pinichpongse S, Malikul S, Rooney W & Tansophalaks S (1990) Phase III double-blind comparative study of Fansimef® and Lariam® for the curative treatment of Plasmodium falciparum infections in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 21, 404-411.
32. Weinke T, Trautmann M, Held T et al. (1991) Neuropsychiatric side effects after the use of mefloquine. American Journal of Tropical Medicine and Hygiene 45, 86-91.
33. World Health Organization (1989) Prophylactic and therapeutic use of mefloquine. Weekly Epidemiological Record 64, 247-248.
34. World Health Organization (1991) Review of central nervous system adverse events to the amimalarial drug mefloqume (1985-1990) Unpublished document WHO/mal 91.1063. WHO, Geneva.